Reporting owner · CIK 0001750050

Sukhatme Mayukh

Visual SEC Form 4 history across 1 companies, 24 transactions and 3 filings.

PRES, CIOPresident & CIORoivant Sciences Ltd.
Open-market mix
Latest filingAug 22, 2026, 01:00 AM
Filings3Form 4 records
Buying$00 purchases
Selling$45.5M8 sales
Net value−$45.5MBuys minus sells
Companies12 securities
Most recentAug 21, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-101Feb 267Aug 26

Net value flow

Buys minus sells

Feb 26
−$9M
Aug 26
−$36.5M

Transaction texture

Ownership and ticket size

Average P/S size$5.7M
Median P/S size$5.9M
Direct24
Indirect0
Aug 21, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Derivative Transactionfiling-context7Direct Ownershipfiling-context24Large Salesize7Repeat Sellerpattern6

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Roivant Sciences Ltd. on Aug 21, 2026 valued at $5,280,699.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Roivant Sciences Ltd. on Aug 21, 2026 valued at $5,280,699.

Review SEC filing

Associated companies

Visual map of known reporting history

ROIVRoivant Sciences Ltd.24 transactions · latest Aug 22, 2026, 01:00 AM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
ROIVSukhatme Mayukh
PRESCIO
exercise144k$0M
Derivative Transaction Direct Ownership
−4.4%08/2208/21
ROIVSukhatme Mayukh
PRESCIO
exercise17.5k$0M
Derivative Transaction Direct Ownership
−4.4%08/2208/20
ROIVSukhatme Mayukh
PRESCIO
exercise172k$0M
Derivative Transaction Direct Ownership
−4.4%08/2208/19
ROIVSukhatme Mayukh
PRESCIO
sale144k-$528MS
Direct Ownership Large Sale Repeat Seller
−4.4%08/2208/21
ROIVSukhatme Mayukh
PRESCIO
exercise144k$55.7MM
Direct Ownership
−4.4%08/2208/21
ROIVSukhatme Mayukh
PRESCIO
sale17.5k-$65.3MS
Direct Ownership Repeat Seller
−4.4%08/2208/20
ROIVSukhatme Mayukh
PRESCIO
exercise17.5k$6.74MM
Direct Ownership
−4.4%08/2208/20
ROIVSukhatme Mayukh
PRESCIO
sale172k-$642MS
Direct Ownership Large Sale Repeat Seller
−4.4%08/2208/19
ROIVSukhatme Mayukh
PRESCIO
exercise172k$66.5MM
Direct Ownership
−4.4%08/2208/19
ROIVSukhatme Mayukh
PRESCIO
exercise136k$0M
Derivative Transaction Direct Ownership
−7.7%08/1908/18

Sukhatme Mayukh Insider Activity FAQ

SEC Form 4 context

Who is Sukhatme Mayukh?

Sukhatme Mayukh is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001750050.

Which companies has Sukhatme Mayukh reported transactions for?

Roivant Sciences Ltd.

When was Sukhatme Mayukh's latest insider buy?

No open-market insider purchase is available for this period.

When was Sukhatme Mayukh's latest insider sale?

sale at Roivant Sciences Ltd. on Aug 21, 2026 valued at $5,280,699.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.